Showing results (1-10 of 439) with videos related to
Sort By:
Pageof 44
Expert Review of Anticancer Therapy|September 21, 2011
Determination of cut-offs for circulating tumor cell measurement in metastatic cancerJimmy Jacob, Jonathan Krell, Leandro Castellano, et al.Expert Review of Anticancer Therapy|November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.Expert Review of Anticancer Therapy|November 27, 2012
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathwaysAdam E Frampton, Jonathan Krell, Elisa Giovannetti, et al.Expert Review of Molecular Diagnostics|December 22, 2012
Towards a clinical use of miRNAs in pancreatic cancer biopsiesAdam E Frampton, Tamara M H Gall, Leandro Castellano, et al.Expert Review of Molecular Diagnostics|February 7, 2015
Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreasAdam E Frampton, Justin Stebbing, Tamara M H Gall, et al.Expert Review of Molecular Diagnostics|March 13, 2013
Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancerTamara M H Gall, Adam E Frampton, Jonathan Krell, et al.Expert Review of Molecular Diagnostics|October 17, 2013
Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?Tamara M H Gall, Adam E Frampton, Jonathan Krell, et al.The Medico-Legal Journal|June 11, 2014
Cancer: Where were we, where are we, where are we goingJustin StebbingPageof 44